Latest news with #PeterGoldschmidt
Daily Mirror
02-07-2025
- Health
- Daily Mirror
UK tops all other countries in Europe for boozing and one key reason blamed
A new survey has found that the UK has the highest number of people who drink alcohol at least once a week than any other country in Europe, with one key reason why people drink emerging The UK tops the charts for weekly alcohol consumption, with more Brits confessing to drinking at least once a week than any other European nation, according to recent data. A fresh survey revealed that 46% of Brits admit to having a drink at least once every seven days. This is closely followed by Ireland, where 45% partake in weekly drinking, and the Netherlands and Spain, both at 42%. The study, conducted by pharmaceutical firm STADA, surveyed 27,000 individuals across 22 countries. The primary reason participants gave for consuming alcohol was to boost their mood, with 31% citing this as their main motivation. Meanwhile, 23% claimed it helped them unwind or sleep, and 18% used it as a stress reliever. The data also highlighted that men were significantly more likely to drink on a weekly basis than women - 44% of men compared to 25% of women. They were also twice as likely to indulge in daily drinking (6% versus 3%), reports Surrey Live. Interestingly, nearly a third of women (32%) confessed they didn't know why they drank, compared to 23% of men. In terms of smoking, 31% of Europeans light up a cigarette or use other tobacco products at least once a week. The survey discovered that Bulgaria had the highest percentage of weekly smokers (47%), followed by Serbia, with 42%. Peter Goldschmidt, CEO of STADA, has observed that while many Europeans are keen on preventative health measures and maintaining healthy habits, there's a limit to what they can achieve. He explained: "Stagnating system satisfaction, limited access to preventative and mental healthcare and a perceived lack of fairness fuel frustrations across the continent. "In their private lives, many Europeans find themselves torn between knowing what is best for them and simultaneously being pulled in another direction by their circumstances and day-to-day responsibilities." The NHS advises the consumption of no more than 14 units of alcohol per week, optimally spread over at least three days. This amounts to around six standard glasses of wine or six pints of beer with a 4% ABV. The health service highlights multiple benefits of reducing alcohol intake such as feeling less fatigued, achieving clearer skin, saving funds, decreasing blood pressure, diminishing risks of stroke and cancer, and lowering cholesterol levels. Enhanced moods, improved memory and sleep, along with assistance in weight management, are also cited as advantageous outcomes of cutting down on booze. A significant portion (49%) of the European populace recognises the potential to embark on healthier lifestyle choices. Amongst those yearning for betterment, 39% indicated that reduced workplace stress would help alter detrimental habits, and 36% expressed a desire for a calmer home life to facilitate positive changes. The NHS clarifies that consuming more than 14 units of alcohol a week for a decade or longer can lead to serious health conditions such as mouth cancer, throat cancer, breast cancer, stroke, heart disease, liver disease, brain damage, and damage to the nervous system.
Yahoo
17-03-2025
- Business
- Yahoo
German Drugmaker Stada Is Pushing Back IPO Until September
(Bloomberg) -- Stada Arzneimittel AG's private equity owners are pushing back a planned initial public offering of the German drugmaker until September, people with knowledge of the matter said. ICE Eyes Massive California Tent Facility Amid Space Constraints How Britain's Most Bike-Friendly New Town Got Built Washington, DC, Region Braces for 'Devastating' Cuts from Congress The Dark Prophet of Car-Clogged Cities Saving the Signature Sound of Washington, DC Bain Capital and Cinven decided to delay the listing due to the recent market volatility, the people said, asking not to be identified because the information is private. They had originally planned to launch the share sale as soon as this week, according to the people. Stada was looking at a valuation of roughly €10 billion ($10.9 billion) from the planned offering, Bloomberg News has reported. It was targeting to raise around €1.5 billion of fresh capital from the IPO, in addition to any selldown from its private equity owners, people with knowledge of the matter have said. A first-time share sale for Stada was expected to kickstart IPO activity in Europe. Oldenburgische Landesbank AG, the German regional lender backed by Apollo Global Management Inc., has also been gearing up for a share sale. Deliberations are ongoing and details of Stada's listing plans could still change, the people said. Representatives for Bain, Cinven and Stada declined to comment. Stada sells generic drugs, consumer health products and specialty medication for rare and chronic diseases. Its brands include Grippostad, which helps treat colds and flu infections, and Hirudoid cream for bruises and hematoma. The company is seeking to slash its debt pile by around €3 billion, from its current level of €5.6 billion, Chief Executive Officer Peter Goldschmidt said in a February interview. JPMorgan Chase & Co., Morgan Stanley, Deutsche Bank AG and Goldman Sachs Group Inc. are leading the Stada IPO as global coordinators, people with knowledge of the matter have said. (Updates with background from fifth paragraph.) The Real Reason Trump Is Pushing 'Buy American' Nvidia Looks Past DeepSeek and Tariffs for AI's Next Chapter How America Got Hooked on H Mart How Trump's 'No Tax on Tips' Could Backfire for the Working Class Snap CEO Evan Spiegel Bets Meta Can't Copy High-Tech Glasses ©2025 Bloomberg L.P. Sign in to access your portfolio
